Matthew Bell
Angel Investor · at SC Launch, Inc.
Detroit, United States
Matthew Bell is a seed investor at SC Launch, Inc. in Detroit focused on Software and Health Diagnostics. Matthew Bell is based out of Detroit, Michigan and Matthew previously worked at South Carolina Research Authority as a Executive Director, SC Launch Inc. Investment Fund. Matthew attended the Gies College of Business - University of Illinois Urbana-Champaign.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 63%
Last updated:
For AI agents: llms.txt
Industries Matthew Bell invests in
Stages Matthew Bell invests in
Countries Matthew Bell invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 5 (63%)
- Health Diagnostics 2 (25%)
- Information Technology 2 (25%)
- Internet 1 (13%)
- GreenTech 1 (13%)
Stage
- Seed 3 (38%)
- Pre-Seed 2 (25%)
- Series A 2 (25%)
- Funding Round 1 (13%)
Country
- United States 6 (75%)
- Canada 1 (13%)
- United Kingdom 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Leukogene Therapeutics is Charleston, SC based oncology focused biotech company, a spin-out from the Medical University of South Carolina (MUSC). Their mission is to deliver innovative immunotherapies for hard-to-treat cancers with emphasis on immunologically “cold” tumors. Leukogene’s MHC class II targeted M2T™ immunotherapy directs and mobilizesthe immune system to trigger a robust, tumor antigen specific immune response and eliminate tumor cells. Their lead candidates in acute myeloid leukemia (AML) and pancreatic ductal adenocarcinoma (PDAC) have already demonstrated preclinical proof of concept. | Nov 12, 2025 | ||
| CADchat provides a cloud-based digital workspace tailored for product, engineering, and manufacturing teams. The platform enables live collaboration on native 3D CAD files without requiring screen sharing or file conversion across formats. | Seed / Aug 01, 2024 | ||
| Bubble Paper designs and leverages best-in-class technologies to deliver optimized paper-based packaging solutions to the industrial, void fill, and cold chain markets. The company has developed a proprietary process that maximizes the potential of forming paper into mechanically and thermally protective packaging designs that were previouslyunachievable. All Bubble Paper product offerings emphasize environmental sustainability and are fully curbside recyclable. Current products include Bubble Paper cushioning wrap, Paper Icebox™ thermal box liners, and bubble paper mailers | $10M / Series A / Jul 23, 2024 | ||
| PulManage is a software platform used for remote monitoring to track changes with clinician surveillance. The platform connects patients and providers to lower overall costs, create an additional revenue stream, and increase the quality of life for patients. It provides a web portal for clinicians and a mobile application paired with a BT lungfunction device for patients. The system sends signals designed to allow providers to confirm obstructive patterns and stay connected to patients at risk of exacerbation. | $250K / Seed / May 29, 2024 | ||
| Pixlmob designed software that connects photographers and videographers with authorized editors that give image alterations to increase the quality and visibility of images and films. | $700K / Pre-Seed / Sep 06, 2023 | ||
| New Forge is a system integrator and technology supplier of AR software and hardware. New Forge helps businesses reduce downtime and increase ROI with wearable solutions using augmented reality and assisted reality technologies. | $250K / Pre-Seed / Feb 07, 2023 | ||
| Get full-time balance with the smart matching site for shared roles. | $1.2M / Seed / Aug 17, 2022 | ||
| AbCelex Technologies is a biotechnology company that develops solutions which focus on animal health and food safety challenges. It focuses on swine, poultry, and other farm animals. AbCelex Technologies develops protein feed that is able to prevent and treat a number of bacterial infections in animals. It offers NF-220, sdAb-based proteinfragments. AbCelex Technologies was founded by Saeid Babaei in 2010. It is based in Mississauga, Ontario. | $2M / Series A |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Matthew Bell invest in?
Matthew Bell invests primarily in Software, Health Diagnostics and Information Technology startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Matthew Bell?
Public channels for Matthew Bell include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Matthew Bell last invest?
The most recent investment recorded for Matthew Bell closed in Nov 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
